title: A paradigm shift in pulmonary arterial hypertension management.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, and 6 Dept of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. 2 Dept of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, Bologna, Italy. 3 Université Paris-Sud, Le Kremlin-Bicêtre, 4 AP-HP, Service de Pneumologie, TORINO Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, and 5 INSERM U999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France.
authors.forename: Lewis J
authors.initials: LJ
authors.lastname: Rubin
authors.forename: Nazzareno
authors.initials: N
authors.lastname: Galiè
authors.forename: Gérald
authors.initials: G
authors.lastname: Simonneau
authors.forename: Vallerie
authors.initials: V
authors.lastname: McLaughlin
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D062186:Arterial Pressure / Q000187:drug effects*; D004059:Diffusion of Innovation; D005080:Exercise Test; D017079:Exercise Tolerance / Q000187:drug effects; D065627:Familial Primary Pulmonary Hypertension; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D011237:Predictive Value of Tests; D011651:Pulmonary Artery / Q000187:drug effects* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents